Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination

Background: Identification of human papillomavirus type 16 (HPV16) as the major risk factor for cervical neoplasia, and mass production of DNA free HPV capsids have paved the way to preventive vaccination trials. Design of such trials requires reliable attack rate data. Objective: Determination of (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kibur, M, Geijerstamm, V, Pukkala, E, Koskela, P, Luostarinen, T, Paavonen, J, Schiller, J, Wang, Z, Dillner, J, Lehtinen, M
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2000
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1760571/
https://ncbi.nlm.nih.gov/pubmed/10817062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/sti.76.1.13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados